Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Children with MDD
NCT01198795Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Sep 2010; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01198795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198795.